Spectrum Pharmaceuticals, Inc.

SPPI

Statistics

$19.00Share Price
$1.6 BMarket Cap
N/AEBIT / EV
N/AFCF / EV
N/AROIC
N/ACash ROIC
-1.0%3yr Avg Revenue Growth
5.04Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark Cannot calculate EBIT / Enterprise Value, company has negative EBIT.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
x mark Cannot calculate Return on Invested Capital, company has negative EBIT.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
x mark The 3 Year Average Revenue Growth Value of -1.0% ranks as Below Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 5.04.

Company Description

Spectrum Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It targets non-Hodgkin's lymphoma, advanced metastatic colorectal cancer, acute lymphoblastic leukemia, and multiple myeloma. It operates through the following brands: FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, EVOMELA, EOQUIN, and RenaZorb. The company was founded in December 1987 and is headquartered in Henderson, NV.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!